Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

Aflibercept, Medicine, FOLFIRI, Irinotecan, Bevacizumab, Internal medicine, Oncology, KRAS, Regimen, Colorectal cancer, Capecitabine, Progression-free survival, Oxaliplatin, Surgery, Cancer, Chemotherapy